SCHEMBL1477415

SCHEMBL1477415

C#Cc1ncccc1C(=O)CC(=O)OC.c1cc2cc-2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLCG1 P19174 1/20 0.37
DHODH Q02127 6/20 0.36
PKM P14618 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
P2RX7 Q99572 1/20 0.34
EGLN1 Q9GZT9 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
HPGD P15428 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
VEGFA P15692 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477041 0.84 TDP1 (0.45) PLCG1DHODHPKML3MBTL1KMT2A
Hydrochloric Acid SCHEMBL1477231 0.83 TDP1 (0.44) PLCG1DHODHPKML3MBTL1KMT2A
SCHEMBL1477295 0.80 RORB (0.38) PLCG1DHODHL3MBTL1KMT2AMEN1
SCHEMBL834846 0.79 TSHR (0.46) L3MBTL1NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL835282 0.78 KDM4E (0.47) DHODHPKML3MBTL1SMN1; SMN2TDP1
SCHEMBL1476510 0.78 TRPM8 (0.37) PLCG1DHODHPKMKMT2AMEN1
SCHEMBL1479640 0.77 PARP1 (0.47) NPC1RAB9ASMN1; SMN2KMT2AMEN1
Hydrochloric Acid SCHEMBL1476864 0.76 PARP1 (0.46) NPC1RAB9ASMN1; SMN2KMT2AMEN1
Hydrochloric Acid SCHEMBL1476697 0.75 MEN1 (0.41) SMN1; SMN2KMT2AMEN1RORB
SCHEMBL1476600 0.74 ADRA1A (0.33) PLCG1DHODHRORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915424-B2 Analgesics; anxiolytic agents ELI LILLY AND COMPANY (US) 2011-03-29 US disclosed
EP-1729771-B1 PYRIDYL DERIVATIVES AND THEIR USE AS MGLU5 RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-14 EP disclosed
US-20080194647-A1 Pyridyl Derivatives and Their Use as Mglu5 Antagonists ELI LILLY AND COMPANY (US) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194647-A1 Pyridyl Derivatives and Their Use as Mglu5 Antagonists HRH4, CNR2, CNR1 PLCG1 2534/4885DHODH 2249/4885PKM 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.